The expression and clinical diagnostic value of miRNA in patients with hyperlipidemic pancreatitis

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1800015085

Enrollment

Unknown

Registered

2018-03-06

Start date

2017-12-01

Completion date

Unknown

Last updated

2018-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperlipidemic acute pancreatitis

Interventions

Case series:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) meet the Atlanta new classification criteria for patients with acute pancreatitis in 2012; (2) Aged from 18 to 65 years; (3) The hospital ethics committee approve the protocol,also all patients provide written informed consent before enrollment.

Exclusion criteria

Exclusion criteria: (1) Patients with malignant disease; (2) pregnancy or postpartum patients; (3) Patients with psychiatric or refuse to cooperate.

Design outcomes

Secondary

Measure	Time frame
amylase;lipase;	—

Primary

Measure	Time frame
serum miRNA;	—

Countries

China

Contacts

Public ContactLijun Tang

Chengdu Military General Hospital

tanglj2016@163.com+86 13258198900

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026